Browsing Tag

Formulary

Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage

Jason Junior Jun 22, 2023

HOUSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving…

Health

Quit Genius Selected for Evernorth Digital Health Formulary to Provide Alcohol and Opioid Use…

Jason Junior Sep 15, 2022

NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Two additional solutions by Quit Genius, the world’s first digital clinic for treating multiple substance addictions, have been added to the Evernorth Digital Health Formulary, which connects…

Health

SCYNEXIS Secures Additional Commercial Insurance Formulary Coverage for BREXAFEMME® (ibrexafungerp…

Jason Junior Apr 19, 2022

JERSEY CITY, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced…

Health

BREXAFEMME® (ibrexafungerp tablets) Added to Major National Formulary, Providing Access for Millions…

Jason Junior Dec 20, 2021

JERSEY CITY, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced…

Health

Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary

Jason Junior Oct 4, 2021

PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that the California Medicaid Program, Medi-Cal, has placed Twirla on the preferred drug formulary…